Health Catalyst, Inc. (HCAT) Earnings History
Annual and quarterly earnings data from 2017 to 2025
Loading earnings history...
HCAT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
HCAT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 48.7% | -51.7% | -57.2% |
| 2024 | 45.9% | -22.8% | -22.7% |
| 2023 | 44.5% | -42.9% | -39.9% |
| 2022 | 48.2% | -50.7% | -49.7% |
| 2021 | 48.6% | -59.4% | -63.3% |
Download Data
Export HCAT earnings history in CSV or JSON format
Free sign-in required to download data
Health Catalyst, Inc. (HCAT) Earnings Overview
As of May 8, 2026, Health Catalyst, Inc. (HCAT) reported trailing twelve-month net income of -$178M, reflecting -121.7% year-over-year growth. The company earned $-2.51 per diluted share over the past four quarters, with a net profit margin of -57.2%.
Looking at the long-term picture, HCAT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$47M in fiscal 2017.
Health Catalyst, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HIMS ($128M net income, 5.5% margin), DOCS ($239M net income, 39.1% margin), INVA ($504M net income, 63.8% margin), HCAT has room to improve margins relative to the peer group. Compare HCAT vs HIMS →
HCAT Earnings vs Peers
Earnings metrics vs comparable public companies
HCAT Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$178M | -156.1% | -$161M | $-2.55 | -57.2% | -51.7% |
| 2024 | -$70M | +41.2% | -$70M | $-1.15 | -22.7% | -22.8% |
| 2023 | -$118M | +14.0% | -$127M | $-2.09 | -39.9% | -42.9% |
| 2022 | -$137M | +10.3% | -$140M | $-2.54 | -49.7% | -50.7% |
| 2021 | -$153M | -33.2% | -$144M | $-3.23 | -63.3% | -59.4% |
| 2020 | -$115M | -91.4% | -$96M | $-2.91 | -60.9% | -50.9% |
| 2019 | -$60M | +3.0% | -$55M | $-3.21 | -38.8% | -35.4% |
| 2018 | -$62M | -31.8% | -$60M | $-2.23 | -55.1% | -53.4% |
| 2017 | -$47M | - | -$46M | $-1.69 | -64.4% | -62.3% |
See HCAT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HCAT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HCAT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHCAT — Frequently Asked Questions
Quick answers to the most common questions about buying HCAT stock.
Is HCAT growing earnings?
HCAT EPS fell to $-2.51, with earnings declining -121.7%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-178M.
What are HCAT's profit margins?
Health Catalyst, Inc. net margin is -57.2%, with operating margin at -51.7%. Below-average margins reflect competitive or cost pressures.
How consistent are HCAT's earnings?
HCAT earnings data spans 2017-2025. The declining earnings trend is -121.7% YoY. Historical data enables comparison across business cycles.